BackAlamar Biosciences Overview

Alamar Biosciences Long Term Debt

Track Alamar Biosciences's long-term debt ($340M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$338.95M

Peer average / median

Loading

Alamar Biosciences Long Term Debt History

Loading

Alamar Biosciences vs. peers: Long Term Debt Comparison

Loading

Alamar Biosciences Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alamar Biosciences (ALMR) FAQ

Alamar Biosciences (ALMR) currently reports a long-term debt of $340M as of March 2026. Use the charts on this page to explore Alamar Biosciences's long-term debt history and peer comparisons.

Alamar Biosciences reported $340M in long-term debt as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $340M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alamar Biosciences, and consider following ALMR for alerts when major investors trade the stock.

Alamar Biosciences is classified in the Healthcare sector. On long-term debt, it currently shows $340M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALMR with unrelated industries.